Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

BACKGROUND: Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for the vaccine developing world. Here we demonstrate that it is possible to harness the physiological proper...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Mohsen, Mona O., Heath, Matthew D., Cabral-Miranda, Gustavo, Lipp, Cyrill, Zeltins, Andris, Sande, Marcos, Stein, Jens V., Riether, Carsten, Roesti, Elisa, Zha, Lisha, Engroff, Paul, El-Turabi, Aadil, Kundig, Thomas M., Vogel, Monique, Skinner, Murray A., Speiser, Daniel E., Knuth, Alexander, Kramer, Matthias F., Bachmann, Martin F.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6485085/
https://ncbi.nlm.nih.gov/pubmed/31027511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0587-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados